LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,827,267 | -31.0% | 310,068 | -29.1% | 0.01% | -16.7% |
| Q2 2023 | $30,200,694 | +135.5% | 437,501 | +64.5% | 0.01% | +100.0% |
| Q1 2023 | $12,825,845 | +24.5% | 265,986 | +28.9% | 0.00% | +50.0% |
| Q4 2022 | $10,303,638 | -54.6% | 206,403 | -62.9% | 0.00% | -60.0% |
| Q3 2022 | $22,712,000 | -1.3% | 556,658 | +33.1% | 0.01% | 0.0% |
| Q2 2022 | $23,008,000 | +72.6% | 418,328 | +14.0% | 0.01% | +66.7% |
| Q1 2022 | $13,332,000 | +30.6% | 366,864 | +67.5% | 0.00% | +50.0% |
| Q4 2021 | $10,209,000 | +169.8% | 219,034 | +192.7% | 0.00% | +100.0% |
| Q3 2021 | $3,784,000 | +71.5% | 74,844 | +39.2% | 0.00% | – |
| Q2 2021 | $2,207,000 | +808.2% | 53,757 | +542.9% | 0.00% | – |
| Q1 2021 | $243,000 | -40.4% | 8,362 | -42.3% | 0.00% | – |
| Q4 2020 | $408,000 | – | 14,483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $66,470,000 | 19.56% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,466,453 | $59,831,000 | 8.69% |
| Paradigm Biocapital Advisors LP | 1,076,591 | $43,925,000 | 5.86% |
| HHLR ADVISORS, LTD. | 5,136,617 | $209,574,000 | 5.51% |
| RA Capital Management | 2,338,610 | $95,415,000 | 2.04% |
| Nicholas Investment Partners, LP | 399,486 | $16,299,000 | 1.51% |
| Parkman Healthcare Partners LLC | 121,227 | $4,946,000 | 1.41% |
| Capital International, Inc./CA/ | 1,244,362 | $50,770,000 | 1.13% |
| AtonRa Partners | 28,150 | $1,149,000 | 1.13% |
| Vivo Capital, LLC | 244,375 | $9,971,000 | 1.10% |